Abstract
Background
We examined the ability of a procalcitonin (PCT) protocol to detect vesicoureteral reflux (VUR) and renal scarring (RS), evaluated procedural costs and radiation burden, and compared four representative guidelines for children with their first febrile urinary tract infection (UTI).
Methods
Children aged ≤2 years with their first febrile UTI who underwent renal ultrasonography (US), acute and late technetium-99m (99mTc)-dimercaptosuccinic acid scan, and voiding cystourethrography were prospectively studied. The representative guidelines applied in a retrospective simulation included the American Academy of Pediatrics (AAP), National Institute of Clinical Excellence, top-down approach (TDA), and Italian Society of Pediatric Nephrology (ISPN). These were compared in terms of ability to detect abnormalities, procedural costs and radiation.
Results
Of 278 children analyzed, 172 (61.9 %) had acute pyelonephritis. There was VUR in 101 (36.3 %) children, including 73 (26.3 %) with grades III–V VUR. RS was identified in 75 (27.0 %) children. To detect VUR, TDA and PCT had the highest sensitivity for grades I–V VUR (80.2 %) and III–V VUR (94.5 %), respectively, whereas AAP had the highest specificity for I–V VUR (77.4 %) and III–V VUR (78.0 %), respectively. TDA and PCT had the highest sensitivity (100 %) for detecting RS. The highest cost and radiation dose was associated with TDA, whereas AAP had the least expenditure and radiation exposure. By multivariate analysis, PCT and VUR, especially grades III–V, were independent predictors of RS.
Conclusions
There is no perfect guideline for first febrile UTI children. The PCT protocol has good ability for detecting high-grade VUR and RS. If based on available imaging modalities and reducing cost and radiation burden, clinical suggestions in the AAP guidelines represent a considerable protocol.
Similar content being viewed by others
References
Subcommittee on Urinary tract Infection, Steering Committee on Quality Improvement and Management (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128:595–610
Stefanidis CJ, Siomou E (2007) Imaging strategies for vesicoureteral reflux diagnosis. Pediatr Nephrol 22:937–947
Rushton HG (1997) The evaluation of acute pyelonephritis and renal scarring with technetium 99 m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions. Pediatr Nephrol 11:108–120
Moorthy I, Easty M, McHugh K, Ridout D, Biassoni L, Gordon I (2005) The presence of vesicoureteric reflux does not identifying a population at risk for renal scarring following a first urinary tract infection. Arch Dis Child 90:733–736
Lahdes-Vasama T, Niskanen K, Rönnholm K (2006) Outcome of kidneys in patients treated for vesicoureteral reflux (VUR) during childhood. Nephrol Dial Transplant 21:2491–2497
Faust W, Diaz M, Pohl H (2009) Incidence of post-pyelonephritic renal scarring: a meta-analysis of the dimercapto-succinic acid literature. J Urol 181:290–298
Shaikh N, Ewing AL, Bhatnagar S, Hoberman A (2010) Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 126:1084–1091
Orellana P, Baquedano P, Rangarajan V, Zhao JH, Eng ND, Fettich J, Chaiwatanarat T, Sonmezoglu K, Kumar D, Park YH, Samuel AM, Sixt R, Bhatnagar V, Padhy AK (2004) Relationship between acute pyelonephritis, renal scarring, and vesicoureteral reflux. Pediatr Nephrol 19:1122–1126
National Institute for Health and Clinical Excellence (2007) Urinary tract infection in children: diagnosis, treatment and long term management. Available at: www.nice.org.uk/nicemedia/pdf/CG54fullguideline.pdf. (Date accessed 15 Jun 2013)
Preda I, Jodal U, Sixt R, Stokland E, Hansson S (2007) Normal dimercaptosuccinic acid scintigraphy makes voiding cystourethrography unnecessary after urinary tract infection. J Pediatr 151:581–584
Ammenti A, Cataldi L, Chimenz R, Fanos V, Manna AL, Marra G, Materssi M, Pcecile P, Pennesi M, Pisanello L, Sica F, Toffolo A, Montini G (2012) Febrile urinary tract infections in young children: recommendations for the diagnosis, treatment and follow-up. Acta Paediatr 101:451–457
La Scola C, De Mutiis C, Hewitt IK, Puccio G, Toffolo A, Zucchtta P, Mencarelli F, Marsciani M, Dall’Amico R, Montini G (2013) Different guidelines for imaging after first UTI in febrile infants: yield, cost, and radiation. Pediatrics 131:e665–e671
Sun HL, Wu KH, Chen SM, Chao YH, Ku MS, Hung TH, Liao PF, Lue KH, Sheu JN (2013) Role of procalcitonin in predicting dilating vesicoureteral reflux in young children hospitalized with a first febrile urinary tract infection. Pediatr Infect Dis J 32:e348–e354
Sheu JN, Chang HM, Chen SM, Hung TW, Lue KH (2011) The role of procalcitonin on acute pyelonephritis and subsequent renal scarring in infants and young children. J Urol 186:2002–2009
Avni EF, Ayadi K, Rypens F, Hall M, Schulman CC (1997) Can careful ultrasound examination of the urinary tract exclude vesicoureteric reflux in the neonate? Br J Radiol 70:977–982
Mandell GA, Eggli DF, Gilday DL, Heyman S, Leonard JC, Miller JH, Nadel HR, Treves ST (1997) Procedure guideline for renal cortical scintigraphy in children. J Nucl Med 38:1644–1646
Sheu JN, Wu KH, Chen SM, Tsai JD, Chao YH, Lue KH (2013) Acute 99mTc DMSA scan predicts dilating vesicoureteral reflux in young children with a first febrile urinary tract infection: a population-based cohort study. Clin Nucl Med 38:163–168
Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER (2003) Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 348:195–202
Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE (1985) International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol 15:105–109
Smith T, Evans K, Lythgoe MF, Anderson PJ, Gordon I (1996) Radiation dosimetry of texhnetium-99 m-DMSA in children. J Nucl Med 37:1336–1342
Tseng MH, Lin WJ, Lo WT, Wang SR, Chu ML, Wang CC (2007) Does a normal DMSA obviate the performance of voiding cystourethrography in evaluation of young children after their first urinary tract infection. J Pediatr 150:96–99
Lee MD, Lin CC, Huang FY, Tsai TC, Huang CT, Tsai JD (2009) Screening young children with a first febrile urinary tract infection for high-grade vesicoureteral reflux with renal ultrasound scanning and technetium-99-labelled dimercaptosuccinic acid scanning. J Pediatr 154:797–802
Hansson S, Dhamey M, Sigström O, Sixt R, Stokland E, Wennerström M, Jodal U (2004) Dimercapto-succinic acid scintigraphy instead of voiding cystourethrography for infants with urinary tract infection. J Urol 172:1071–1073
Swerkersson S, Jodal U, Sixt R, Stokland E, Hansson S (2007) Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children. J Urol 178:647–651
Jakobsson B, Soderlundh S, Berg U (1992) Diagnostic significance of 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy in urinary tract infection. Arch Dis Child 67:1338–1342
Ditchfield MR, Grimwood K, Cook DJ, Powell HR, Sloane R, Gulati S, De Campo JF (2004) Persistent renal cortical scintigram defects in children 2 years after urinary tract infection. Pediatr Radiol 34:465–471
Lee YJ, Lee JH, Park YS (2012) Risk factors for renal scar formation in infants with first episode of acute pyelonephritis: a prospective clinical study. J Urol 187:1032–1036
Coulthard MG (2009) Vesicoureteral reflux is not a benign condition. Pediatr Nephrol 24:227–232
Montini G, Tullus K, Hewitt I (2011) Febrile urinary tract infection in children. N Engl J Med 365:239–250
Ardissino G, Avolio L, Dacco V, Testa S, Marra G, Viganò S, Loi S, Caione P, De Castro R, De Pascale S, Marras E, Riccipetitoni G, Selvaggio G, Pedotti P, Claris-Appiani A, Giofani A, Dello Strologo L, Lama G, Montini G, Verrina E (2004) Long-term outcome of vesicourerteral reflux associated chronic renal failure in children. Data from the Italkid project. J Urol 172:305–310
Leroy S, Fernandez-Lopez A, Nikfar R, Romanello C, Bouissou F, Gervaix A, Gurgoze MK, Bressan S, Smolkin V, Tuerlinckx D, Stefanidis CJ, Vaos G, Leblond P, Gungor F, Gendrel D, Chalumeau M (2013) Association of procalcitonin with acute pyelonephritis and renal scars in pediatric UTI. Pediatrics 131:870–879
Chen SM, Cheng HM, Hung TW, ChaoY-H TJD, Lue KH, Sheu JN (2013) Diagnostic performance of procalcitonin for hospitalised children with acute pyelonephritis presenting to the paediatric emergency department. Emeg Med J 30:406–410
Bressan S, Andreola B, Zucchetta P, Montini G, Burei M, Perilongo G, Dalt LD (2009) Procalcitonin as a predictor of renal scarring in infants and young children. Pediatr Nephrol 24:1199–1204
Ristola MT, Hurme T (2013) NICE guidelines for imaging studies in children with UTI adequate only in boys under the age of 6 months. Pediatr Surg Int 29:215–222
Acknowledgments
This study was supported by grants from the National Science Council, Taiwan (NSC93-2314-B-040-012) and the Chung Shan Medical University Hospital, Taiwan (CSH-2012-C-010).
Author information
Authors and Affiliations
Corresponding author
Additional information
Pei-Fen Liao and Min-Sho Ku contributed equally to this work.
Rights and permissions
About this article
Cite this article
Liao, PF., Ku, MS., Tsai, JD. et al. Comparison of procalcitonin and different guidelines for first febrile urinary tract infection in children by imaging. Pediatr Nephrol 29, 1567–1574 (2014). https://doi.org/10.1007/s00467-014-2801-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-014-2801-z